<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[2, 3] chemotherapy<br>[124, 125] chemotherapy<br>[128, 129] vincristine<br>[135, 140] cyclophosphamide and 5-fluoro-uracil<br>[146, 151] doxorubicine or/and with methotrexate.<br>[162, 163] doxorubicine<br></td>
<td width=33%>
[2, 3] chemotherapy<br>[124, 125] chemotherapy<br>[128, 129] vincristine<br>[135, 140] cyclophosphamide and 5-fluoro-uracil<br>[146, 151] doxorubicine or/and with methotrexate.<br>[159, 163] combined therapy using doxorubicine<br>[243, 244] chemotherapy<br>[252, 255] anticancer therapy.<br></td>
<td width=33%>
[2, 3] chemotherapy<br>[124, 125] chemotherapy<br>[128, 151] vincristine associated for the one part with cyclophosphamide and 5-fluoro-uracil and on the other hand with doxorubicine or/and with methotrexate.<br>[159, 163] combined therapy using doxorubicine<br>[217, 219] complex therapy<br>[243, 244] chemotherapy<br>[252, 255] anticancer therapy.<br></td>
</tr>
